Hereditary atrial fibrillation

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

No FDA or trial events recorded yet for Hereditary atrial fibrillation.

Financial Assistance

No financial assistance programs currently listed for Hereditary atrial fibrillation.
Check the disease page for updates →

Approved Treatments

2 FDA-approved

So-Aqueous

(sotalol (IV))Orphan drugstandard

AltaThera Pharmaceuticals LLC

XARELTO

(RIVAROXABAN)standard

Janssen Pharmaceuticals, Inc.

Factor Xa Inhibitor [EPC]

12.1 Mechanism of Action XARELTO is a selective inhibitor of FXa. It does not require a cofactor (such as Anti-thrombin III) for activity. Rivaroxaban...

FDA label ↗

View full treatment details on disease page →

Clinical Trial Landscape

No active clinical trials currently recruiting for Hereditary atrial fibrillation.
Search all trials →
Search clinical trials for Hereditary atrial fibrillation

Recent News & Research

No recent news articles indexed yet for Hereditary atrial fibrillation.
Search PubMed for Hereditary atrial fibrillation

Browse all Hereditary atrial fibrillation news →

Specialist Network

Top 6 by expertise

View all Hereditary atrial fibrillation specialists →

Quick Actions